Which medications in the drug class Antifibrinolytic agents are used in the treatment of Factor XIII Deficiency?

Updated: Aug 01, 2019
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Perumal Thiagarajan, MD  more...
  • Print

Antifibrinolytic agents

These agents are used as an ancillary measure and to diminish bleeding.

Aminocaproic acid (Amicar)

EACA diminishes bleeding by inhibiting lysis of hemostatic plugs. Can be used PO or IV.

Tranexamic acid injection (Cyklokapron)

Diminishes bleeding by inhibiting fibrinolysis of hemostatic plug. A PO form is also available.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!